相关实验视频

Updated: Jun 9, 2026

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

甲福明的使用和骨髓扩散性瘤的风险:一项基于丹麦人口的病例控制研究

Daniel Tuyet Kristensen^1,2,3, Andreas Kiesbye Øvlisen^1,2, Lasse Hjort Kyneb Jakobsen¹

¹Department of Haematology, Clinical Cancer Research Center, Aalborg University Hospital, Aalborg, Denmark.

|May 17, 2024

概括

甲胺使用与发展骨髓增殖性瘤 (MPN) 的风险降低有关. 这表明甲胺的潜在癌症预防作用,特别是在长期使用时.

科学领域:

在瘤学瘤学.
药理学药理学是指药理学的学科.
流行病学流行病学

背景情况:

甲福明是众所周知的降糖效应.
新出现的证据表明,甲福明具有抗瘤和癌症预防性质.

研究的目的:

调查甲福明使用与骨髓增殖性瘤 (MPN) 风险之间的关联.

主要方法:

基于人口的病例控制研究,使用丹麦的登记.
确定了3816个MPN病例和19080个匹配的对照.
在MPN诊断之前评估的甲福明使用情况和计算的几率比率 (ORs).

主要成果:

甲胺使用与MPN诊断的几率显著降低相关 (aOR=0.70).
长期使用甲素 (≥5年) 显示出更强的相关性 (aOR=0.45).
观察到一种剂量-反应关系,在各个子组中一致.

结论:

梅特福林的使用与MPN诊断的几率降低有关.
这些发现表明,甲胺的潜在癌症预防作用.
由于研究设计是追溯的,因此无法推断因果关系.

更多相关视频

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Studying Pancreatic Cancer Stem Cell Characteristics for Developing New Treatment Strategies

Published on: June 20, 2015

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

相关概念视频

Oral Hypoglycemic Agents: Biguanides and Glitazones

Oral Hypoglycemic Agents: Biguanides and Glitazones

Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...